Paul H. Gale
- Molecular Biology
- Biochemistry top 1%
- Pharmacology top 5%
- Physiology
- Organic Chemistry top 10%
- Co-authors
- Robert W. EganF. A. KuehlKarl FolkersA. C. PageEdward A. HamD.D. SodermanW.J.A. VandenheuvelFrank R. Koniuszy
- Topics
- Coenzyme Q10 studies and effects (12 papers)Inflammatory mediators and NSAID effects (9 papers)Eicosanoids and Hypertension Pharmacology (7 papers)
- Cited by
- BiochemistryPharmacology
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Paul H. Gale
32 papers receiving 971 citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 530
- Biochemistry 355
- Pharmacology 241
- Physiology 178
- Organic Chemistry 172
Countries citing papers authored by Paul H. Gale
This map shows the geographic impact of Paul H. Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H. Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H. Gale more than expected).
Fields of papers citing papers by Paul H. Gale
This network shows the impact of papers produced by Paul H. Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H. Gale. The network helps show where Paul H. Gale may publish in the future.
Co-authorship network of co-authors of Paul H. Gale
This figure shows the co-authorship network connecting the top 25 collaborators of Paul H. Gale. A scholar is included among the top collaborators of Paul H. Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H. Gale. Paul H. Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 6 | |
| 3 | 43 | |
| 4 | 9 | |
| 5 | 14 | |
| 6 | 33 | |
| 7 | 92 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 2 | |
| 11 | 189 | |
| 12 | 31 | |
| 13 | 47 | |
| 14 | 2 | |
| 15 | 11 | |
| 16 | 17 | |
| 17 | 30 | |
| 18 | 22 | |
| 19 | 58 | |
| 20 | 86 |
About Paul H. Gale
Paul H. Gale is a scholar working on Biochemistry, Pharmacology and Pharmacology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Coenzyme Q10 studies and effects (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). The work is most often cited by research in Biochemistry (355 citations), Pharmacology (241 citations) and Pharmacology (107 citations). Paul H. Gale has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert W. Egan, F. A. Kuehl, Karl Folkers, A. C. Page, Edward A. Ham, D.D. Soderman, W.J.A. Vandenheuvel, Frank R. Koniuszy, Nelson R. Trenner and Byron H. Arison. Their work appears in journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.